Skip to main content

Mindfulness-Based Cognitive Therapy application for People Living with Chronic Disease: the case of HIV

  • Chapter
  • First Online:

Abstract

People living with HIV (PLWH) must face a wide variety of stress factors, both physical and psychological, that interact with each other, depleting their resources to cope with the ensuing challenges. As a result, depression and psychological stress are very common among those in this population. The aim of this chapter is to show the potential therapeutic effects that mindfulness-based cognitive therapy (MBCT) has on promoting their well-being. To accomplish this, first we briefly describe the current issues that this population, as well as their caretakers, must face. Also, we will present the rationale for applying MBCT in PLWH and the specific modifications that will help to make the program successful. Next, in order to illustrate the way in which the program can be adapted to the challenges of PLWH, we present two clinical cases. Subsequently, we review the special considerations surrounding the implementation of MBCT. With the goal of incorporating all of the research that has been carried out so far, we propose a meta-model that identifies a common structure that attempts to explain the mechanisms of change that underlie the effects on well-being of mindfulness-based interventions (MBIs). The model identifies three mechanisms of change: attention, meta-awareness, and self-regulation, along with their main brain-related areas, and explains how they are interrelated. Finally, we suggest future directions to continue expanding MBCT research.

The real voyage of discovery consists not in seeking new landscapes,

but in having new eyes

Marcel Proust

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

AIDS:

Acquired immune deficiency syndrome

ART:

Antiretroviral therapy

HIV:

Human immunodeficiency virus

MBCT:

Mindfulness-based cognitive therapy

MBIs:

Mindfulness-based interventions

MSM:

Men who have sex with men

PLWH:

People who live with HIV

RCT:

Randomized controlled trial

References

  1. Harden VA. Aids at 30: a history. Washington, DC: Potomac; 2012.

    Google Scholar 

  2. Tomes N. The gospel of germs: men, women and the microbe in American life. Cambridge: Harvard University; 1999.

    Google Scholar 

  3. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425–31.

    Article  CAS  PubMed  Google Scholar 

  4. UNAIDS. The GAP report. Joint United Nations Programme on HIV/AIDS. Geneva: United Nations; 2014.

    Google Scholar 

  5. Coffin JM, Hugues SH, Varmus HE. Retroviruses. New York, NY: Cold Spring Harbor Laboratory; 1997.

    Google Scholar 

  6. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60.

    Article  PubMed  Google Scholar 

  7. Van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS. 2003;17:2227–36.

    Article  PubMed  Google Scholar 

  8. Bangsberg DR, Porco TC, Kagay C, Charlebois ED, Deeks SG, Guzman D, et al. Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates. J Infect Dis. 2004;190:162–5.

    Article  CAS  PubMed  Google Scholar 

  9. Bhatia R, Ryscavage P, Babafeni T. Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol. 2012;18:247–55.

    Article  CAS  PubMed  Google Scholar 

  10. Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47:542–53.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med. 2007;146:87–95.

    Article  PubMed  Google Scholar 

  13. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–9.

    Article  Google Scholar 

  14. May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, et al. Impact of late diagnosis and treatment on life-expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ. 2011;343:d6016.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Marzolini C, Back D, Weber R, Furrer H, Cavassini M, Calmy A, et al. Ageing with HIV: medication use and risk for potential drug–drug interactions. J Antimicrob Chemother. 2011;66:2107–11.

    Article  CAS  PubMed  Google Scholar 

  16. Rockwood K. Frailty and its definition: a worthy challenge. J Am Geriatr Soc. 2005;53:1069.

    Article  PubMed  Google Scholar 

  17. Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. Multicenter AIDS Cohort Study. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007;62:1279–86.

    Article  PubMed  Google Scholar 

  18. Nasi M, Pinti M, De Biasi S, Gibellini L, Ferraro D, Mussini C, et al. Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV. Immunol Lett. 2014;162:329–33.

    Article  CAS  PubMed  Google Scholar 

  19. Tsoukas C. Immunosenescence and aging in HIV. Curr Opin HIV AIDS. 2014;9:398–404.

    Article  CAS  PubMed  Google Scholar 

  20. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16:238–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Moskowitz JT, Wrubel J, Hult JR, Maurer S, Acree M. Illness appraisals and depression in the first year after HIV diagnosis. PLoS One. 2013;8, e78904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Howland LC, Gortmaker SL, Mofenson LM, Spino C, Gardner JD, Gorski H, et al. Effects of negative life events on immune suppression in children and youth infected with human immunodeficiency virus type 1. Pediatrics. 2000;106:540–6.

    Article  CAS  PubMed  Google Scholar 

  23. Fumaz C, Muñoz-Moreno J, Ferrer M, Gonzalez-Garcia M, Perez-Alvarez N, Miranda C, et al. Aging-associated symptoms in the physician-patient dialogue in a group of long-term diagnosed HIV-infected individuals. J Int AIDS Soc. 2012;15:18164.

    Google Scholar 

  24. Ballester-Arnal R, Gomez-Martinez S, Fumaz CR, Gonzalez-Garcia M, Eduardo Remor E, Fuster MJ. A Spanish study on psychosocial predictors of quality of life in people with HIV. AIDS Behav. 2015. doi:10.1007/s10461-015-1208-6.

    Google Scholar 

  25. Mundt C, Reck C, Backenstrass M, Kronmüller K, Fiedler P. Reconfirming the role of life events for the timing of depressive episodes. A two-year prospective follow-up study. J Affect Disord. 2000;59:23–30.

    Article  CAS  PubMed  Google Scholar 

  26. Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140:774–815.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Komiti A, Judd F, Grech P, Mijch A, Hoy J, Williams B, et al. Depression in people living with HIV/AIDS attending primary care and outpatient clinics. Aust N Z J Psychiatry. 2003;37:70–7.

    Article  PubMed  Google Scholar 

  28. Judd F, Komiti A, Chua P, Mijch A, Hoy J, Grech P, et al. Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry. 2005;39:826–32.

    Article  PubMed  Google Scholar 

  29. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–8.

    Article  CAS  PubMed  Google Scholar 

  30. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725–30.

    Article  CAS  PubMed  Google Scholar 

  31. Emlet CA. “You’re awfully old to have this disease”: experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS. Gerontologist. 2006;46:781–90.

    Article  PubMed  Google Scholar 

  32. Fumaz CR, Muñoz-Moreno JA, Ferrer MJ, Gonzalez-Garcia M, Negredo E, Perez-Alvarez N, et al. Emotional impact of premature aging symptoms in long-term treated HIV-infected subjects. J AIDS. 2012;59:5–8.

    Google Scholar 

  33. McIntosh RC, Rosselli M, Uddin LQ, Antoni M. Neuropathological sequelae of human immunodeficiency virus and apathy: a review of neuropsychological and neuroimaging studies. Neurosci Biobehav Rev. 2015;55:147–64.

    Article  PubMed  Google Scholar 

  34. Cohen SE, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA. 2007;298:1685–7.

    Article  CAS  PubMed  Google Scholar 

  35. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci. 2003;100:9090–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry. 2003;60:1009–14.

    Article  CAS  PubMed  Google Scholar 

  37. Fumaz CR, Gonzalez-Garcia M, Borras X, Muñoz-Moreno JA, Perez-Alvarez N, Mothe B, et al. Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment. Brain Behav Immun. 2012;26:568–72.

    Article  CAS  PubMed  Google Scholar 

  38. Patterson S, Moran P, Epel E, Sinclair E, Kemeny ME, Deeks SG, et al. Cortisol patterns are associated with T cell activation in HIV. PLoS One. 2013;8, e63429.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Maes M, Berk M, Goehler L, Song C, Anderson G, Gałecki P, et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012;10:66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Antoni MH. Stress, coping, and health in HIV/AIDS. In: Folkman S, editor. The Oxford handbook of stress, health, and coping. Oxford: Oxford University; 2010. p. 428–42.

    Google Scholar 

  41. Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R. Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med. 2007;69:217–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Von Känel R, Dimsdale JE, Ancoli-Israel S, Mills PJ, Patterson TL, McKibbin CL, et al. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer’s disease. J Am Geriatr Soc. 2006;54:431–7.

    Article  Google Scholar 

  43. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33–44.

    Article  CAS  PubMed  Google Scholar 

  44. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, editors. Handbook of life stress, cognition, and health. New York, NY: Wiley; 1988. p. 629–49.

    Google Scholar 

  45. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. New York, NY: Delta; 1990.

    Google Scholar 

  46. Turner-Cobb JM, Gore-Felton C, Marouf F, Koopman C, Kim P, Israelski D, et al. Coping, social support, and attachment style as psychosocial correlates of adjustment in men and women with HIV/AIDS. J Behav Med. 2002;25:337–53.

    Article  PubMed  Google Scholar 

  47. Logsdon-Conradsen S. Using mindfulness meditation to promote holistic health in individuals with HIV/AIDS. Cogn Behav Pract. 2002;9:67–72.

    Article  Google Scholar 

  48. Vago DR, Silbersweig DA. Self-awareness, self-regulation, and self-transcendence (S-ART): a framework for understanding the neurobiological mechanisms of mindfulness. Front Hum Neurosci. 2012;6:296.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Turner K. The promotion of successful aging through mindfulness skills training. Doctorate in Social work (DSW) dissertations, paper 1; 2010.

    Google Scholar 

  50. Valiente-Barroso C. Practica de la meditación y neuroprotección frente a la demencia: profundizando en el concepto de reserva cerebral. In: Perez Serrano S, editor. Envejecimiento activo y solidaridad intergeneracional: claves para un envejecimiento activo. Madrid: UNED; 2012. p. 65.

    Google Scholar 

  51. Creswell JD, Myers HF, Cole SW, Irwin MR. Mindfulness meditation training effects on CD4? T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behav Immun. 2009;23:184–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Sibinga EM, Stewart M, Magyari T, Welsh CK, Hutton N, Ellen JM. Mindfulness-based stress reduction for HIV-infected youth: a pilot study. Explore (NY). 2008;4:36–7.

    Article  Google Scholar 

  53. Jam S, Imani AH, Foroughi M, SeyedAlinaghi S, Koochak HE, Mohraz M. The effects of mindfulness-based stress reduction (MBSR) program in Iranian HIV/AIDS patients: a pilot study. Acta Med Iran. 2010;48:101–6.

    PubMed  Google Scholar 

  54. SeyedAlinaghi S, Jam S, Foroughi M, Imani A, Mohraz M, Djavid GE, et al. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4? T lymphocyte count and medical and psychological symptoms. Psychosom Med. 2012;74:620–7.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Gayner B, Esplen MJ, Deroche P, Wong J, Bishop S, Kavanagh L, et al. A randomized controlled trial of mindfulness-based stress reduction to manage affective symptoms and improve quality of life in gay men living with HIV. J Behav Med. 2012;35:272–85.

    Article  PubMed  Google Scholar 

  56. Robinson FP, Mathews HL, Witek-Janusez L. Psycho-endocrine-immune response to mindfulness-based stress reduction in individuals infected with the human immunodeficiency virus: a quasiexperimental study. J Altern Complement Med. 2003;9:683–94.

    Article  PubMed  Google Scholar 

  57. Duncan LG, Moskowitz JT, Neilands TB, Dilworth SE, Hecht FM, Johnson MO. Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial. J Pain Symptom Manage. 2012;43:161–71.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Riley KE, Kalichman S. Mindfulness-based stress reduction for people living with HIV/AIDS: preliminary review of intervention trial methodologies and findings. Health Psychol Rev. 2015;9:224–43.

    Article  PubMed  Google Scholar 

  59. Wood NA. Mindfulness-based cognitive therapy for the symptoms of depression in a community-based HIV/AIDS clinic: outcomes and feasibility. Chester: Widener University; 2008.

    Google Scholar 

  60. Gonzalez-Garcia M, Ferrer MJ, Borras X, Muñoz-Moreno JA, Miranda C, Puig J, et al. Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV Infection. AIDS Behav. 2014;18(4):676–85.

    Article  Google Scholar 

  61. Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol Sci Pract. 2003;10(2):125–43.

    Article  Google Scholar 

  62. Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse. New York, NY: Guilford; 2002.

    Google Scholar 

  63. Gonzalez Garcia M. Mindfulness y VIH. Efecto sobre calidad de vida, estrés percibido, estado emocional y situación inmunológica. Doctoral dissertation, Barcelona: Autonomous University of Barcelona, Barcelona; 2012.

    Google Scholar 

  64. Folkman S, Chesney MA, Christopher-Richards A. Stress and coping in caregiving partners of men with AIDS. Psychiatr Clin North Am. 1994;17:35–53.

    CAS  PubMed  Google Scholar 

  65. Moskowitz LG, Duncan PJ, Moran M, Acree ES, Epel ME, Kemeny FM, et al. Dispositional mindfulness in people with HIV: associations with psychological and physical health. Pers Indiv Differ. 2015;86:88–93.

    Article  Google Scholar 

  66. Krasner MS, Epstein RM, Beckman H, Suchman AL, Chapman B, Mooney CJ, et al. Association of an educational program in mindful communication with burnout, empathy, and attitudes among primary care physicians. JAMA. 2009;302:1284–93.

    Article  CAS  PubMed  Google Scholar 

  67. Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev. 2015;37:1–12.

    Article  CAS  PubMed  Google Scholar 

  68. Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol. 2006;62:373–86.

    Article  PubMed  Google Scholar 

  69. Brown KW, Ryan RM, Creswell JD. Mindfulness: theoretical foundations and evidence for its salutary effects. Psychol Inq. 2007;18:211–37.

    Article  Google Scholar 

  70. Grabovac AD, Lau MA, Willett BR. Mechanisms of mindfulness: a Buddhist psychological model. Mindfulness. 2011;2:154–66.

    Article  Google Scholar 

  71. Hölzel BK, Lazar SW, Gard T, Schuman-Olivier Z, Vago DR, Ott U. How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspect Psychol Sci. 2011;6:537–59.

    Article  PubMed  Google Scholar 

  72. Farb NA, Segal ZV, Anderson AK. Mindfulness meditation training alters cortical representations of interoceptive attention. Soc Cogn Affect Neurosci. 2013;8:15–26.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Creswell JD. Biological pathways linking mindfulness with health. In: Brown KW, Creswell JD, Ryan RM, editors. Handbook of mindfulness: theory, research, and practice. New York, NY: Guilford; 2014. p. 426–41.

    Google Scholar 

  74. Tang YY, Hölzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16:213–25.

    Article  CAS  PubMed  Google Scholar 

  75. Posner MI, Rothbart MK. Research on attention networks as a model for the integration of psychological science. Annu Rev Psychol. 2007;58:1–23.

    Article  PubMed  Google Scholar 

  76. Petersen SE, Posner MI. The attention system of the human brain: 20 years after. Annu Rev Neurosci. 2012;35:73–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Chiesa A, Calati R, Serretti A. Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clin Psychol Rev. 2011;31:449–64.

    Article  PubMed  Google Scholar 

  78. Grant JA, Courtemanche J, Duerden EG, Duncan GH, Rainville P. Cortical thickness and pain sensitivity in Zen meditators. Emotion. 2010;10:43–53.

    Article  PubMed  Google Scholar 

  79. Tang YY, Ma Y, Wang J, Fan Y, Feng S, Lu Q, et al. Short-term meditation training improves attention and self-regulation. Proc Natl Acad Sci U S A. 2007;104:17152–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Tang YY, Lu Q, Fan M, Yang Y, Posner MI. Mechanisms of white matter changes induced by meditation. Proc Natl Acad Sci. 2012;109:10570–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Teasdale JD, Segal Z, Williams JM. How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help? Behav Res Ther. 1995;33:25–39.

    Article  CAS  PubMed  Google Scholar 

  82. Lutz A, Dunne JD, Davidson RJ. Meditation and the neuroscience of consciousness. In: Zelazo P, Moscovitch M, Thompson E, editors. Cambridge handbook of consciousness. New York, NY: Cambridge University; 2007. p. 499–555.

    Chapter  Google Scholar 

  83. Lutz A, Brefczynski-Lewis J, Johnstone T, Davidson RJ. Regulation of the neural circuitry of emotion by compassion meditation: effects of meditative expertise. PLoS One. 2008;3, e1897.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Tang YY, Ma Y, Fan Y, Feng H, Wang J, Feng S. Central and autonomic nervous system interaction is altered by short-term meditation. Proc Natl Acad Sci. 2009;106:8865–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Farb NA, Segal ZV, Mayberg H, Bean J, McKeon D, Fatima Z, et al. Attending to the present: mindfulness meditation reveals distinct neural modes of self-reference. Soc Cogn Affect Neurosci. 2007;2:313–22.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Farb NA, Anderson AK, Mayberg H, Bean J, McKeon D, Segal ZV. Minding one’s emotions: mindfulness training alters the neural expression of sadness. Emotion. 2010;10:25–33.

    Article  PubMed  Google Scholar 

  87. Farb NA, Segal ZV, Anderson AK. Attentional modulation of primary interoceptive and exteroceptive cortices. Cereb Cortex. 2013;23:114–26.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Critchley HD, Wiens S, Rotshtein P, Ohman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci. 2004;7:189–95.

    Article  CAS  PubMed  Google Scholar 

  89. Craig AD. How do you feel – now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10:59–70.

    Article  CAS  PubMed  Google Scholar 

  90. Kirk U, Montague PR. Mindfulness meditation modulates reward prediction errors in a passive conditioning task. Front Psychol. 2015;6:90.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Brewer JA, Worhunsky PD, Gray JR, Tang YY, Weber J, Kober H. Meditation experience is associated with differences in default mode network activity and connectivity. Proc Natl Acad Sci U S A. 2011;108:20254–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Marchand WR. Neural mechanisms of mindfulness and meditation: evidence from neuroimaging studies. World J Radiol. 2014;28:471–9.

    Article  Google Scholar 

  93. Karoly P. Mechanisms of self-regulation: a systems view. Ann Rev Psychol. 1993;44:23–52.

    Article  Google Scholar 

  94. Posner MI, Rothbart MK, Sheese BE, Tang Y. The anterior cingulate gyrus and the mechanism of self-regulation. Cogn Affect Behav Neurosci. 2007;7:391–5.

    Article  PubMed  Google Scholar 

  95. Baer RA, Smith GT, Lykins E, Button D, Krietemeyer J, Sauer S, et al. Construct validity of the five facets mindfulness questionnaire in meditating and nonmeditating samples. Assessment. 2008;15:329–42.

    Article  PubMed  Google Scholar 

  96. Heeren A, Deplus S, Peschard V, Nef F, Kotsou I, Dierickx C, et al. Does change in self-reported mindfulness mediate the clinical benefits of mindfulness training? A controlled study using the French translation of the five facet mindfulness questionnaire. Mindfulness. 2015;6:553–9.

    Article  Google Scholar 

  97. Bjorklund DF, Harnishfeger KK. The evolution of inhibition mechanisms and their role in human cognition and behavior. In: Dempster FN, Brainerd CJ, editors. Interference and inhibition in cognition. San Diego, CA: Academic; 1995. p. 142–69.

    Google Scholar 

  98. Nigg JT. On the inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy. Psychol Bull. 2000;126:220–46.

    Article  CAS  PubMed  Google Scholar 

  99. Chiesa A, Serretti A. A systematic review of neurobiological and clinical features of mindfulness meditations. Psychol Med. 2010;40:1239–52.

    Article  CAS  PubMed  Google Scholar 

  100. Tang YY, Yang L, Leve LD, Harold GT. Improving executive function and its neurobiological mechanisms through a mindfulness-based intervention: advances within the field of developmental neuroscience. Child Dev Perspect. 2012;6:361–6.

    PubMed  PubMed Central  Google Scholar 

  101. Zeidan F. The neurobiology of mindfulness meditation. In: Brown KW, Creswell JD, Ryan RM, editors. Handbook of mindfulness: theory, research, and practice. New York, NY: Guilford; 2014. p. 171–89.

    Google Scholar 

  102. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits: a meta analysis. J Psychosom Res. 2004;57:35–43.

    Article  PubMed  Google Scholar 

  103. Keng SL, Smoski MJ, Robins CJ. Effects of mindfulness on psychological health: a review of empirical studies. Clin Psychol Rev. 2011;31:1041–56.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Carlson LE. Mindfulness-based interventions for physical conditions: a narrative review evaluating levels of evidence. ISRN Psychiatry. 2012;2012:651583.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Dodge R, Daly A, Huyton J, Sanders L. The challenge of defining wellbeing. Int J Wellbeing. 2012;2:222–35.

    Article  Google Scholar 

  106. Van der Velden AM, Roepstorff A. Neural mechanisms of mindfulness meditation: bridging clinical and neuroscience investigations. Nat Rev Neurosci. 2015;16:439.

    Article  PubMed  CAS  Google Scholar 

  107. Christopher MS, Gilbert BD. Incremental validity of components of mindfulness in the prediction of satisfaction with life and depression. Curr Psychol. 2009;29:10–23.

    Article  Google Scholar 

  108. Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003;84:822–48.

    Article  PubMed  Google Scholar 

  109. Shapiro SL, Oman D, Thoresen CE, Plante TG, Flinders T. Cultivating mindfulness: effects on well-being. J Clin Psychol. 2008;64:840–62.

    Article  PubMed  Google Scholar 

  110. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med. 2003;65:564–70.

    Article  PubMed  Google Scholar 

  111. Rosenkranz MA, Favidson RJ, MacCoon DG, Sheridan JF, Kalin NH, Lutz A. A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain Behav Immun. 2013;27:174–84.

    Article  PubMed  Google Scholar 

  112. Kaliman P, Alvarez-López MJ, Cosín-Tomás M, Rosenkranz MA, Lutz A, Davidson RJ. Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators. Psychoneuroendocrinology. 2014;40:96–107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Baltes PB, Baltes MM. Psychological perspectives on successful aging: the model of selective optimization and compensation. In: Baltes PB, Baltes MM, editors. Successful aging: percpectives from the behavioral sciences. Cambridge: New York, NY; 1990. p. 1–34.

    Chapter  Google Scholar 

  114. Thayer JF, Ahs F, Fredrikson M, Sollers 3rd JJ, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev. 2012;36:747–56.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marian González-García Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

González-García, M., Borràs, X., López, J.G., McNeil, K.G. (2016). Mindfulness-Based Cognitive Therapy application for People Living with Chronic Disease: the case of HIV. In: Eisendrath, S. (eds) Mindfulness-Based Cognitive Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-29866-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29866-5_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29864-1

  • Online ISBN: 978-3-319-29866-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics